Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.

INTRODUCTION: The use of anticoagulants during continuous renal replacement therapy (CRRT) is essential. Regional citrate anticoagulation (RCA) is recommended rather than systemic heparinization to prolong the filter's lifespan in patients at high risk of bleeding. However, commercial citrate is expensive and may not be available in resource-limited areas. The objective of this study is comparing filter life between our locally made customized RCA and no anticoagulation. The primary outcomes were the first circuit life in hours and the number of filters used within the first 72 h of therapy. METHODS: We conducted a single-center prospective randomized controlled trial in critically ill patients requiring CRRT. The participants were randomized to receive continuous venovenous hemofiltration (CVVH) with either customized RCA or no anticoagulant. RESULTS: Of 76 patients, 38 were randomized to receive customized RCA and 38 to receive CVVH without anticoagulant. There was no significant difference in baseline characteristics between the two groups. Compared to anticoagulant-free group, the median circuit life of customized RCA group was significantly longer [44.9 (20.0, 72.0) vs. 14.3 (7.0, 22.0) hours; p < 0.001]. The number of filters used within 72 h was significant lower [2.0 (1.0, 2.0) vs. 2.5 (1.0, 3.0); p < 0.015]. RCA was prematurely discontinued in 5 patients due to citrate accumulation (2 cases) and severe metabolic acidosis requiring higher dose of CVVH (3 cases). No differences in bleeding complications were observed (p = 0.99). CONCLUSION: Customized citrate-based replacement solution improved filter survival in CVVH compared to anticoagulant-free strategy. This regimen is safe, feasible, and suitable for low- to middle-income countries.

Characteristics and Factors Associated With the Mortality of Hypotensive Patients Attending the Emergency Department.

BACKGROUND: The prevalence of hypotension in emergency departments (EDs) is approximately 1-2%, but is associated with a mortality rate of 8-15%. There has never been a study in Thailand examining the epidemiology or the risk factors for early mortality of patients presenting with hypotension in the ED. Therefore, this study aimed to define the characteristics, mortality rate within 48 h and associated factors of hypotensive patients at ED. METHODS: Data of patients with hypotension attending the ED of Thammasat University Hospital (TUH) were retrospectively studied. RESULTS: Of the 9,000 patients seen in the TUH ED, 233 were hypotensive for a prevalence of 2.5%. Patients were old, with a mean age of 61 ± 20 years. The most common presenting symptom was fever, and sepsis was the most common cause of hypotension. The mean systolic blood pressure (SBP) was 78 ± 8 mm Hg. Isotonic crystalloid volume resuscitation in first hour was 758 mL (interquartile range (IQR), 500 - 1,000) and the total volume to achieve a mean arterial pressure (MAP) ≥ 65 mm Hg was 1,142 mL (IQR, 500 - 1,500). Twenty-seven percent of patients needed vasopressor support. Nineteen patients died ≤ 48 h, giving a case fatality rate of 8.2%. Three independent factors associated with 48-h mortality were initial pulse rate > 100 beats/min (odds ratio (OR), 4.21; 95% confidence interval (CI), 1.05 - 16.88; P = 0.042), diagnosis of shock (OR, 13.74 (1.49 - 126.61); P = 0.021) and recurrent hypotension (OR, 6.91 (1.54 - 30.99); P = 0.012). CONCLUSIONS: Hypotension in the ED was common and associated with high mortality rate. Better triage, patient monitoring and treatment may improve outcomes in these patients.